Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

PHASE1UnknownINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2014

Conditions
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular DegenerationEye DiseasesRetinal Diseases
Interventions
DEVICE

IRay

Low voltage stereotactic radiotherapy system

Trial Locations (1)

04030

Asociación Para Evitar la Ceguera en México, I.A.P., Mexico City

Sponsors
All Listed Sponsors
lead

Oraya Therapeutics, Inc.

INDUSTRY